+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Analgesics Market by Drug Type (Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, Salicylates), Type (Non-Opioids, Opioids), Route of Administration, Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5264364
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Analgesics Market size was estimated at USD 21.85 billion in 2023, USD 23.75 billion in 2024, and is expected to grow at a CAGR of 8.79% to reach USD 39.42 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Analgesics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Analgesics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Analgesics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Assertio Therapeutics, Inc., Bausch Health Companies Inc., Baxter International Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Endo Pharmaceuticals Inc., Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Purdue Pharmaceuticals L.P., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries, Inc., and Teva Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Analgesics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Type
    • Acetaminophen
    • Nonsteroidal Anti-Inflammatory Drugs
    • Salicylates
  • Type
    • Non-Opioids
    • Opioids
  • Route of Administration
    • Intravenous
    • Oral
    • Rectal
    • Topical
    • Transdermal
  • Distribution
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Analgesics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Analgesics Market?
  3. What are the technology trends and regulatory frameworks in the Analgesics Market?
  4. What is the market share of the leading vendors in the Analgesics Market?
  5. Which modes and strategic moves are suitable for entering the Analgesics Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Analgesics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of cardiovascular disease (CVD), cancer, & arthritis
5.1.1.2. Prevalence of regular analgesic treatment has increased among community-dwelling older person
5.1.1.3. Cost-effectiveness of over-the-counter analgesic medications
5.1.2. Restraints
5.1.2.1. Uncontrolled prescriptions of opioids and drug abuse
5.1.3. Opportunities
5.1.3.1. Increasing investments in R&D by the public & private sectors
5.1.3.2. Surge in popularity of personalized medicine
5.1.4. Challenges
5.1.4.1. Limited availability and affordability of high efficacy drugs, including opioid analgesics
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Analgesics Market, by Drug Type
6.1. Introduction
6.2. Acetaminophen
6.3. Nonsteroidal Anti-Inflammatory Drugs
6.4. Salicylates
7. Analgesics Market, by Type
7.1. Introduction
7.2. Non-Opioids
7.3. Opioids
8. Analgesics Market, by Route of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
8.4. Rectal
8.5. Topical
8.6. Transdermal
9. Analgesics Market, by Distribution
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Analgesics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Analgesics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Analgesics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AbbVie Inc.
14.1.2. Assertio Therapeutics, Inc.
14.1.3. Bausch Health Companies Inc.
14.1.4. Baxter International Inc.
14.1.5. Bayer AG
14.1.6. Boehringer Ingelheim International GmbH
14.1.7. Bristol-Myers Squibb Company
14.1.8. Eli Lilly and Company
14.1.9. Endo Pharmaceuticals Inc.
14.1.10. Glaxosmithkline PLC
14.1.11. Johnson & Johnson Services, Inc.
14.1.12. Novartis AG
14.1.13. Pfizer Inc.
14.1.14. Purdue Pharmaceuticals L.P.
14.1.15. Reckitt Benckiser Group PLC
14.1.16. Sun Pharmaceutical Industries, Inc.
14.1.17. Teva Pharmaceutical Industries Ltd.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. ANALGESICS MARKET RESEARCH PROCESS
FIGURE 2. ANALGESICS MARKET SIZE, 2023 VS 2030
FIGURE 3. ANALGESICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ANALGESICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ANALGESICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ANALGESICS MARKET DYNAMICS
FIGURE 7. ANALGESICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 8. ANALGESICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ANALGESICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. ANALGESICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 12. ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 14. ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANALGESICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ANALGESICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ANALGESICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. ANALGESICS MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Assertio Therapeutics, Inc.
  • Bausch Health Companies Inc.
  • Baxter International Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Endo Pharmaceuticals Inc.
  • Glaxosmithkline PLC
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Purdue Pharmaceuticals L.P.
  • Reckitt Benckiser Group PLC
  • Sun Pharmaceutical Industries, Inc.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information